INTRODUCTION
Regular physical exercise affects bone remodelling. In recent years it has become clear that the cells actively involved in bone remodelling include not only osteoblasts and osteoclasts but also osteocytes.
Bone resorption and bone formation are assessed by measuring the concentrations of certain chemicals referred to as bone turnover markers [1] . The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) suggest using procollagen type I N terminal peptide (P1NP) as a marker of bone formation and C-terminal telopeptide of type I collagen (CTx) as a specific marker of bone resorption [2] .
It should be noted here that while the above markers of bone turnover reflect the main functions of osteoblasts and osteoclasts, they do not take into consideration the significant role of osteocytes.
Sclerostin seems to be a good marker of bone turnover that is involved in bone remodelling and may reflect the activity of osteocytes [3] .
Sclerostin is a product of the SOST gene, which is located in the 17q12-21 chromosomal region. Sclerostin acts as a negative regulator of bone formation, through inhibition of the Wnt signalling pathways, which is of critical importance for the development and function of osteoblasts [4] . Sclerostin is a glycoprotein that belongs , p= <0.0001). Vitamin D deficiency was found in 77% of A and 100% of NA. A and NA had similar daily energy intake. They did not differ as to the intake of calcium and vitamin D. We observed a negative correlation between the serum concentrations of sclerostin and calcium in the studied subjects. Our results suggest that regular, long-lasting physical training may be associated with higher concentration of sclerostin. It seems that increased sclerostin is not related to other bone turnover markers (PTH, P1NP). to the DAN family of bone morphogenetic protein (BMP) antagonists [5] and contains a C-terminal cysteine knot-like domain [5, 6] .
Sclerostin as a novel marker of bone turnover in athletes AUTHORS
The expression of sclerostin by osteocytes is regulated by mechanical forces and hormones known to affect bone metabolism, such as parathyroid hormone, calcitonin and glucocorticoids [7] .
Mechanical stimulation of the skeleton induces bone formation through either exercise or experimental loading, while immobilisation increases the number of sclerostin positive osteocytes [8, 9] . Sclerostin concentrations are also affected by sex steroids [10] .
Sclerostin changes bone mass through alterations in osteocyte and osteoblast Wnt and prostacyclin signalling pathways [11] .
Sclerostin influences vitamin D metabolite concentrations, the concentrations of phosphaturic peptides such as fibroblast growth factor 23 (FGF-23), and the renal handling of calcium and phosphorus [12] . In the absence of sclerostin, concentrations of the active metabolite of vitamin D 1α,25(OH)2D are increased, whereas concentrations of the inactive metabolite of vitamin D 24,25(OH)2D are decreased [13, 14] . In the absence of sclerostin the excretions of urinary Ca is diminished, suggesting a direct effect of the protein on renal Ca excretion. To respond to alterations in bone mass, 1,25(OH)2D
and FGF-23 concentrations are altered, as is the renal excretion of calcium, thereby resulting in a positive calcium and phosphorus balance [12, 15] .
Physical exercise affects serum sclerostin levels. Sclerostin concentrations decrease in response to mechanical strain [16, 17] and increase during bed rest [9] . However, an increase of sclerostin concentration has been observed as a consequence of a 3-week bicycle race [18] . There are only a few reports in the available literature on the effects of regular physical activity of several years' duration (the case of professional athletes) on basal serum concentrations of sclerostin [19, 20, 21] . Therefore we wanted to compare concentrations of sclerostin, selected markers of bone turnover (PTH, P1NP) and 25(OH)D3 in professional athletes and male controls characterized by a low level of physical activity.
MATERIALS AND METHODS
The study was conducted in December in 59 healthy males aged 
Biochemical analysis
Blood sampling was carried out fasting at 8.00 am (after a 24-hour period without training in the group of football players). Serum was separated from the samples and stored at -70°C. Sclerostin concentrations were determined by ELISA (Biomedica, Austria). The intra-and interassay of coefficients of variation were 5% and 4% and the limit of detection was 2.6 pmol · l -1 . Serum calcium was determined by colorimetry using the Konelab 60 system (bioMérieux, France). The intra-and interassay CVs were 1.4% and 1.95%, and the limit of detection was 0.36 mmol · l -1 (1.4 mg · dl -1 ).
Statistical analysis
Statistical analyses were performed using PQStat for Windows (version 
RESULTS
The results of the study are summarised in Table 1 . There were no significant differences in the values of anthropometric parameters between the group of athletes (A) and non-athletes (NA). The mean concentration of sclerostin in A was significantly higher than in NA. The athletes had higher concentrations of P1NP and 25(OH)D3 and lower concentrations of PTH. We did not find any significant differences in the intake of calcium, vitamin D or energy between the two study groups.
Assuming the concentrations of serum 25(OH)D3 in the range
30-50 ng · ml -1 are the physiological norm [22] , we found that only 14% of A fulfilled this criterion while 76.7% had vitamin D deficiency. In the control group, 100% of the subjects were vitamin D deficient.
We found a significant negative correlation (r= -0.28) between serum sclerostin and serum calcium in the studied subjects.
DISCUSSION
The literature reports on the concentrations of sclerostin in athletes compared with non-active individuals are scarce and inconclusive.
Lombardi et al. [21] , investigating sclerostin concentrations in elite athletes, found higher sclerostin concentrations in males per- ).
Fazeli et al. [20] investigated 50 adolescents between 15 and 21 years of age and also noted higher sclerostin concentrations in athletes compared to non-athletes. Grasso et al. [18] followed 9 professional cyclists during a cycling stage race and found an increasing trend for sclerostin plasma concentration (day 1, 12, 23 of race).
Moreover, sclerostin concentration was correlated with the effort, the urine Ca, and the muscular activity [18] .
It is not clear why sclerostin concentrations might be higher in athletes compared to non-athletes. Circulating sclerostin concentration may, for instance, reflect total-body skeletal mass, as a larger skeleton may simply produce and release more sclerostin into the circulation. In contrast to what would normally be expected, given that sclerostin is a potent inhibitor of the Wnt signalling pathway, serum sclerostin concentrations have been found to be positively associated with bone mineral mass [23] . Furthermore, it may well be that higher concentrations of sclerostin in athletes are associated with counteracting the constant increases in bone formation and bone mass from repetitive mechanical loading.
It should also be noted that our study was carried out in December, at the end of the competitive period, following a long (8-month) training period. As has been previously reported [24, 25] , the concentrations of bone markers are affected by the time of sampling within the training period.
A factor that is undoubtedly adding to the divergence and inconsistency is that the available assays measure different components of the sclerostin molecule [26] .
Our results are in line with those reported by Bell et al. [27] , who D3 in the athletes studied by us may have resulted from the fact that they had more frequent and longer exposure to sunlight (outdoor training). We did not observe any association between serum concentrations of sclerostin and 25(OH)D3 in the studied subjects.
Similar results were presented by Dawson-Hughes et al. [19] . Treatment with vitamin D did, however, increase serum sclerostin concentrations in healthy older men [29] .
We observed a highly significant difference between A and NA in regard to PTH and P1NP serum concentrations. PTH in A was lower than in NA, which was consistent with the observation by Durosier et al. [26] . Several studies have demonstrated that PTH concentrations do not change or increase during exercise [27, 30, 31, 32, 33, 34] . Lower concentrations of PTH coupled with higher cal- A negative correlation is thus observed between PTH and sclerostin concentrations [26, 35, 36, 37] . Like Mirza et al. [38] , in premenopausal women we did not observe correlations between the concentrations of sclerostin and PTH in the studied men.
Our findings suggest that high levels of physical activity may be associated with higher concentration of P1NP -the most specific marker of bone formation. In contrast with these, Scott et al. [39] found that exercise of high intensity did not affect the concentrations of such bone turnover markers as P1NP or bone alkaline phosphatase.
They did, however, suggest that the concentrations of bone formation markers might increase after a prolonged period of physical activity.
The high level of P1NP responsible for bone formation in football players may be a reflection of the dynamic changes in the bone that are associated with the repair of microinjuries caused by physical activity. Our study also showed a negative correlation of circulating sclerostin concentrations with serum calcium levels. It is consistent with the recent findings reported by Amrein et al. [40] .
Mödder et al. [10] studied men aged 20 to 39 years and similarly to us did not find any significant correlation of sclerostin concentrations with such markers of bone turnover as PTH and P1NP. Durosier et al. [26] also found no association of sclerostin concentrations with those of PTH and 1,25(OH)2D. However, after adjustment for bone mineral mass, serum sclerostin concentration was inversely associated with PTH, 25(OH)D3 and P1NP (after adjustment for sex).
A weak correlation was also observed between the changes in serum sclerostin concentrations and P1NP (adjusted for age and BMI) in the group of premenopausal women [16] . Fazeli et al. [20] , on the other hand, found a positive association between sclerostin and P1NP.
CONCLUSIONS
Our results suggest that professional, years-long training in athletes may be associated with increased serum concentration of sclerostin.
We did not find any significant correlation between sclerostin and the other markers of bone turnover (PTH, P1NP) in the studied subjects.
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